Roivant Sciences (ROIV) Change in Cash (2020 - 2026)
Roivant Sciences' (ROIV) quarterly Change in Cash came in at -$1.2 billion in Q4 2025, up 72.81% YoY from -$715.8 million in Q4 2024, and down 85261.7% on a QoQ basis from -$1.4 million in Q3 2025.
Roivant Sciences (ROIV) Change in Cash (2020 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has 6 years of Change in Cash data on file, last reported at -$1.2 billion in Q4 2025.
- Quarterly Change in Cash rose 72.81% year-over-year to -$1.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.3 billion (down 78.17% YoY) and the FY2026 annual result came in at -$1.3 billion, up 66.15% from the prior year.
- Change in Cash declined to -$1.2 billion in Q4 2025, from -$1.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $5.0 billion in Q4 2023 to a low of -$4.5 billion in Q4 2024.
- A 5-year average of -$506.9 million and a median of -$242.5 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash jumped 1036.84% — and 2024, when it tumbled 13748.95%.
- Tracing ROIV's Change in Cash over 5 years: stood at $84.5 million in 2021, then tumbled by 731.07% to -$533.0 million in 2022, then jumped by 1036.84% to $5.0 billion in 2023, then sank by 191.1% to -$4.5 billion in 2024, then jumped by 72.81% to -$1.2 billion in 2025.
- The last three Change in Cash figures came in at -$1.2 billion (Q4 2025), -$1.4 million (Q3 2025), and -$1.5 billion (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -170.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -170.44 Mn |
| Dec 31, 2025 | -1.24 Bn |
| Sep 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | -1.48 Bn |
| Dec 31, 2024 | -4.55 Bn |
| Sep 30, 2024 | -3.66 Bn |
| Jun 30, 2024 | -857.15 Mn |
| Dec 31, 2023 | 4.99 Bn |
| Sep 30, 2023 | -26.46 Mn |
| Jun 30, 2023 | -242.47 Mn |
| Dec 31, 2022 | -533.00 Mn |
| Sep 30, 2022 | -343.82 Mn |
| Jun 30, 2022 | -117.57 Mn |
| Dec 31, 2021 | 84.46 Mn |
| Sep 30, 2021 | 500.75 Mn |
| Jun 30, 2021 | -133.30 Mn |
| Dec 31, 2020 | -483.58 Mn |
| Jun 30, 2020 | 44.32 Mn |